SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-004349
Filing Date
2020-12-17
Accepted
2020-12-17 17:07:35
Documents
56
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q organicell_10q-013120.htm 10-Q 425415
2 CERTIFICATION organicell_ex3101.htm EX-31.1 7897
3 CERTIFICATION organicell_ex3102.htm EX-31.2 8116
4 CERTIFICATION organicell_ex3201.htm EX-32.1 3218
5 CERTIFICATION organicell_ex3202.htm EX-32.2 3295
  Complete submission text file 0001683168-20-004349.txt   2597079

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bpsr-20200131.xml EX-101.INS 423908
7 XBRL SCHEMA FILE bpsr-20200131.xsd EX-101.SCH 33255
8 XBRL CALCULATION FILE bpsr-20200131_cal.xml EX-101.CAL 38405
9 XBRL DEFINITION FILE bpsr-20200131_def.xml EX-101.DEF 107381
10 XBRL LABEL FILE bpsr-20200131_lab.xml EX-101.LAB 213148
11 XBRL PRESENTATION FILE bpsr-20200131_pre.xml EX-101.PRE 175013
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 201396953
SIC: 3790 Miscellaneous Transportation Equipment